All In MedTech

Device Trial Radar · NCT04968847

FemaSeed LOCAL Artificial Insemination Trial

LOCAL: Prospective Multi-Center LOCALized Directional Insemination Trial for Artificial Insemination

Last checked: Nov 19, 2026Latest source record: Nov 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

314

Actual

Start

Jul 15, 2021

Primary completion

Dec 31, 2023

Study completion Apr 30, 2024

Sponsor

Lead sponsor
Femasys Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jul 20, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Female only, from 19 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Brief Summary: The objectives of the trial are to evaluate the safety and effectiveness of the FemaSeed Localized Directional Insemination for artificial insemination, now known as the FemaSeed Intratubal Insemination since FDA Cleared under K231730 in September 2023.

Conditions

  • Infertility
  • Male Factor

Interventions

  • FemaSeed Localized Directional InseminationDevice

    Subjects undergoing FemaSeed Artificial Insemination

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Confirmed pregnancy rate at approximately 3 weeks following FemaSeed procedure.Time frame: 3 weeks
  2. Primary Safety: Occurrence of ectopic pregnancy per cycleTime frame: 7 weeks
  3. Primary Safety: Occurrence of uterine perforation per cycleTime frame: At time of procedure

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Elite IVF, PLLC

    Mobile, Alabama

  • Reproductive Associates of Delaware (RAD Fertility)

    Newark, Delaware

  • Women's Medical Research Group, LLC

    Clearwater, Florida

15 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.